Group* | VM# density (means ± S.E.M) |
P
|
---|
Genistein (n = 5) | 0.67 ± 0.17 | P<0.05 |
Control (n = 5) | 1.5 ± 0.23 |  |
- *Genistein group, Genistein was administered intraperitoneally (75 mg/kg/day) for 30 days. Control group received equivalent DMSO. Tumors were conducted immunohistochemical (CD34) and PAS double-staining to distinguish between endothelium-dependent microvessel and vasculogenic mimicry.
- # vasculogenic mimicry density.